No headlines found.
No press releases found.
No news found.
Zentek Ltd is engaged in developing opportunities in the graphene and related nano-materials industry based on its intellectual property, patents, and Albany graphite. The Company's operating segments are Intellectual Property Development, Biotech, and Albany Project. Intellectual Property Development includes the manufacturing and distribution of graphene-related products. Biotech includes service revenue generated through aptamer technology. The Albany Project includes the exploration and evaluation of assets and mineral exploration activities.
Zentek Ltd. trades on the NASDAQ stock market under the symbol ZTEK.
As of August 6, 2026, ZTEK stock price was flat at $0.65 with 89,225 million shares trading.
ZTEK has a beta of 1.12, meaning it tends to be more sensitive to market movements. ZTEK has a correlation of 0.03 to the broad based SPY ETF.
ZTEK has a market cap of $82.91 million. This is considered a Micro Cap stock.
In the last 3 years, ZTEK traded as high as $1.84 and as low as $.37.
ZTEK has underperformed the market in the last year with a return of -20.6%, while SPY returned +23.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ZTEK shares. However, ZTEK has outperformed the market in the last 3 month and 2 week periods, returning +33.0% and +20.5%, while SPY returned +6.5% and +2.8%, respectively. This indicates ZTEK has been having a stronger performance recently.
ZTEK support price is $.61 and resistance is $.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZTEK shares will trade within this expected range on the day.
